Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00294255 · ClinicalTrials.gov registry record · Phase 4
Risperidone Plus Mood Stabilizer in Treatment of Mixed Mania
A Phase 4 study, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- Phase 4
- Development phase
- 45
- Enrollment target
NCT00294255 is a Phase 4 study that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 45 participants.
The verdict
NCT00294255, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 45 participants
- Enrollment target
Study Summary
The study aims to assess the efficacy and tolerability of risperidone added to lithium, valproate or lamotrigine in patients experiencing a manic episode with depressive or irritable features.
Interventions
- DRUG Risperidone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2003-03 |
| Est. Completion | 2006-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00294255
The ClinicalTrials.gov registry entry for NCT00294255 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Risperidone is the first listed.
NCT00294255 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00294255 about?
NCT00294255 is a clinical study titled "Risperidone Plus Mood Stabilizer in Treatment of Mixed Mania". The study aims to assess the efficacy and tolerability of risperidone added to lithium, valproate or lamotrigine in patients experiencing a manic episode with depressive or irritable features.
What is the current status of trial NCT00294255?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 45 participants. The study started on 2003-03. Estimated completion is 2006-10.
What interventions are being tested in trial NCT00294255?
The interventions under investigation include: Risperidone (DRUG).
Who is sponsoring clinical trial NCT00294255?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.